Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | Rivoceranib |
Trade Name | |
Synonyms | YN968D1|Apatinib |
Drug Descriptions |
Rivoceranib (apatinib) is an inhibitor of receptor tyrosine kinases, including KDR (VEGFR2), RET, c-KIT, Src, and PDGFRa, which may result in reduced cell proliferation and inhibition of tumor growth (PMID: 21443688, PMID: 32669874). |
DrugClasses | KIT Inhibitor 57 RET Inhibitor 53 SRC Inhibitor 31 VEGFR2 Inhibitor 37 |
CAS Registry Number | 1218779-75-9 |
NCIT ID | C74012 |